In humans, BRAF(V600E) is by far the most common driver mutation in thyroid cancer mainly comprising papillary thyroid carcinoma (PTC),10,11 whereas less than 5% of non-small cell lung carcinoma (NSCLC) carry this mutation.10 This evidence concerns the gene BRAF and non-small cell lung carcinoma.